Delfi Diagnostics Announces $100 Million Series A Financing to Develop a New Class of Early Detection Liquid Biopsy for Multiple Cancers

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3bGY7EK
via IFTTT